Published in J Biomed Mater Res on January 01, 1986
Clinical benefits and risk analysis of topical hemostats: a review. J Artif Organs (2005) 1.32
The temporal and spatial dynamics of microscale collagen scaffold remodeling by smooth muscle cells. Biomaterials (2009) 1.02
Modulation of material properties of a decellularized myocardial matrix scaffold. Macromol Biosci (2011) 0.97
Enhancing angiogenesis in collagen matrices by covalent incorporation of VEGF. J Mater Sci Mater Med (2006) 0.92
Shaping Lips with Fillers. J Cutan Aesthet Surg (2015) 0.90
Characterization of alkali-treated collagen gels prepared by different crosslinkers. J Mater Sci Mater Med (2007) 0.88
An improved collagen scaffold for skeletal regeneration. J Biomed Mater Res A (2010) 0.88
Fabrication of a PLGA-collagen peripheral nerve scaffold and investigation of its sustained release property in vitro. J Mater Sci Mater Med (2007) 0.80
Renal injury and the application of polysaccharide hemospheres: a laparoscopic experimental model. J Endourol (2008) 0.78
Modulating In Vivo Degradation Rate of Injectable Extracellular Matrix Hydrogels. J Mater Chem B Mater Biol Med (2016) 0.76
Chronological histological changes during bone regeneration on a non-crosslinked atelocollagen matrix. J Bone Miner Metab (2012) 0.76
[Prevention of pocket-related complications following heart rhythm device implantation. D-Stat Hemostat™ versus vacuum drainage]. Herzschrittmacherther Elektrophysiol (2015) 0.75
Tetracycline impregnation affects degradation of porcine collagen matrix in healthy and diabetic rats. Clin Oral Investig (2015) 0.75
Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. J Biol Chem (1986) 2.61
Evaluation of artecoll polymethylmethacrylate implant for soft-tissue augmentation: biocompatibility and chemical characterization. Plast Reconstr Surg (1997) 2.50
Population density and pathology: what are the relations for man? Science (1972) 2.13
Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers. Am J Pathol (1987) 1.67
Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III. J Biol Chem (1987) 1.63
Platelet isoforms of platelet-derived growth factor stimulate fibroblasts to contract collagen matrices. J Clin Invest (1989) 1.36
Human monocyte stimulation of fibroblast growth by a soluble mediator(s). J Reticuloendothel Soc (1980) 1.35
Collagen matrices attenuate the collagen-synthetic response of cultured fibroblasts to TGF-beta. J Cell Sci (1995) 1.34
Possibility of shape conformers of the protein inhibitor of the cyclic adenosine monophosphate dependent protein kinase. Biochemistry (1979) 1.24
Reaction to injectable collagen: results in animal models and clinical use. Plast Reconstr Surg (1987) 1.15
Expression of a stable articular cartilage phenotype without evidence of hypertrophy by adult human articular chondrocytes in vitro. J Orthop Res (1998) 1.14
Antibody response in patients with Gaucher disease after repeated infusion with macrophage-targeted glucocerebrosidase. Blood (1993) 1.13
Antibodies to collagen in scleroderma. Arthritis Rheum (1982) 1.13
Collagen fibrillogenesis in vitro: a characterization of fibril quality as a function of assembly conditions. Coll Relat Res (1985) 1.13
Biochemical and pharmacological characterization of different recombinant acid alpha-glucosidase preparations evaluated for the treatment of Pompe disease. Mol Genet Metab (2008) 1.13
Synergistic action of transforming growth factor-beta and insulin-like growth factor-I induces expression of type II collagen and aggrecan genes in adult human articular chondrocytes. Exp Cell Res (1997) 1.11
TGF-beta 1 stimulates cultured human fibroblasts to proliferate and produce tissue-like fibroplasia: a fibronectin matrix-dependent event. J Cell Physiol (1997) 1.09
Sequence homologies between nucleotide binding regions of CFTR and G-proteins suggest structural and functional similarities. FEBS Lett (1995) 1.05
Amino acid sequence around the active-site selenocysteine of rat liver glutathione peroxidase. Biochim Biophys Acta (1982) 1.04
Purification and characterization of recombinant cystic fibrosis transmembrane conductance regulator from Chinese hamster ovary and insect cells. J Biol Chem (1995) 1.02
TGF-beta in the central nervous system: potential roles in ischemic injury and neurodegenerative diseases. Cytokine Growth Factor Rev (1997) 1.00
Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin. Blood (1998) 1.00
Critical controls in the evaluation of cAMP-dependent protein kinase activity ratios as indices of hormonal action. J Biol Chem (1980) 0.98
A retrospective study of antibodies against basement membrane antigens (type IV collagen and laminin) in patients with primary and secondary Raynaud's phenomenon. Arthritis Rheum (1988) 0.98
Clinical use of injectable bovine collagen: a decade of experience. Clin Mater (1992) 0.97
An examination of the biologic response to injectable, glutaraldehyde cross-linked collagen implants. J Biomed Mater Res (1986) 0.96
The importance of antibody and macrophages in spontaneous and drug-induced regression of the T1699 mammary adenocarcinoma. J Reticuloendothel Soc (1979) 0.95
Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon. Clin Immunol Immunopathol (1993) 0.92
Inhibition and promotion of differentiated-like phenotype of a human lung carcinoma in athymic mice by natural and recombinant forms of transforming growth factor-beta. J Natl Cancer Inst (1989) 0.92
Transgenic expression of a variant of human tissue-type plasminogen activator in goat milk: purification and characterization of the recombinant enzyme. Biotechnology (N Y) (1991) 0.92
Immune response to connective tissue components of the basement membrane. Connect Tissue Res (1982) 0.91
The human immune response to reconstituted bovine collagen. J Immunol (1986) 0.91
The effects of heparin on the physicochemical properties of reconstituted collagen. Coll Relat Res (1988) 0.90
Differential expression of multiple genes during articular chondrocyte redifferentiation. Anat Rec (2001) 0.89
Influence of the extracellular matrix on the proliferative response of human skin fibroblasts to serum and purified platelet-derived growth factor. J Cell Physiol (1988) 0.89
Evidence for suitability of glutathione peroxidase as a protective enzyme: studies of oxidative damage, renaturation, and proteolysis. Arch Biochem Biophys (1983) 0.89
Characterization of multiple charge isomers of the inhibitor protein of the cyclic AMP-dependent protein kinase from bovine heart and rabbit skeletal muscle. Arch Biochem Biophys (1980) 0.88
Locally delivered rhTGF-beta2 enhances bone ingrowth and bone regeneration at local and remote sites of skeletal injury. J Orthop Res (2001) 0.88
Enhanced proliferation and differentiation of human articular chondrocytes when seeded at low cell densities in alginate in vitro. J Orthop Res (2000) 0.87
Comparison of inflammatory changes in established type II collagen- and adjuvant-induced arthritis using outbred Wistar rats. Int J Immunopharmacol (1985) 0.86
Exogenous transforming growth factor-beta 2 enhances connective tissue formation and wound strength in guinea pig dermal wounds healing by secondary intent. Ann Surg (1990) 0.85
Mast cells and their degranulation in the Tsk mouse model of scleroderma. Proc Soc Exp Biol Med (1985) 0.84
In situ cytotoxic T cells in a methylcholanthrene-induced tumor. J Immunol (1978) 0.83
Sequence and structural homology among membrane-associated domains of CFTR and certain transporter proteins. J Protein Chem (1993) 0.83
Oxidation of methionine residues in antithrombin. Effects on biological activity and heparin binding. J Biol Chem (1999) 0.81
Multiple denaturational transitions in fibrillar collagen. Biopolymers (1986) 0.81
Characterization of the release of human monocyte regulators of fibroblast proliferation. J Reticuloendothel Soc (1982) 0.81
Prolactin is an antagonist of TGF-beta activity and promotes proliferation of murine B cell hybridomas. Cell Immunol (1998) 0.81
Mechanism of mastocytoma-mediated suppression of lymphocyte reactivity. J Immunol (1976) 0.81
Biosynthetic and growth abnormalities are associated with high-level expression of CFTR in heterologous cells. Am J Physiol (1996) 0.80
Preparation of [3H]collagen for studies of the biologic fate of xenogenic collagen implants in vivo. J Invest Dermatol (1986) 0.80
Attachment of selenocysteine in the catalytic site of glutathione peroxidase. Biochem Biophys Res Commun (1978) 0.80
Differences in the biological activities of transforming growth factor-beta and platelet-derived growth factor in vivo. Growth Factors (1991) 0.80
Growth factors produced by human embryonic kidney cells that influence megakaryopoiesis include erythropoietin, interleukin 6, and transforming growth factor-beta. J Cell Physiol (1992) 0.80
Characterization of the microheterogeneity of recombinant primate prolactin: implications for posttranslational modifications of the hormone in vivo. Endocrinology (1991) 0.80
Human monocyte modulation of endothelial cells and fibroblast growth: possible mechanism for fibrosis. Clin Immunol Immunopathol (1986) 0.80
Alternative delivery of keratinocytes using a polyurethane membrane and the implications for its use in the treatment of full-thickness burn injury. Burns (1998) 0.80
The effects of different growth factors in subcutaneous wound chambers. Prog Clin Biol Res (1988) 0.78
The preparation and physicochemical characterization of an injectable form of reconstituted, glutaraldehyde cross-linked, bovine corium collagen. J Biomed Mater Res (1986) 0.78
A profile of the behavioral changes produced by facilitation of AMPA-type glutamate receptors. Psychopharmacology (Berl) (1997) 0.78
Mastocytoma-medicated suppression of mixed lymphocyte culture and mitogen responsiveness. Cell Immunol (1976) 0.78
Effect of gold salts, D-penicillamine and benoxaprofen on type II collagen-induced arthritis in rats. Agents Actions (1984) 0.78
Organochlorine pesticides and PCBs along the coast of north Vietnam. Sci Total Environ (1999) 0.78
The effect of platelet releasate on wound healing in animal models. J Am Acad Dermatol (1990) 0.77
Aging does not lessen the effectiveness of TGFbeta2-enhanced bone regeneration. J Bone Miner Res (2003) 0.77
Cell-mediated immunity to homologous basement membrane (type IV) collagen in C57BL/6 mice. Clin Immunol Immunopathol (1981) 0.77
Inhibition of connective tissue formation in dermal wounds covered with synthetic, moisture vapor-permeable dressings and its reversal by transforming growth factor-beta. J Invest Dermatol (1990) 0.77
Inhibition of protein synthesis in vitro by procollagen-derived fragments is associated with changes in protein phosphorylation. J Biol Chem (1982) 0.77
Transforming growth factors-beta 1 and beta 2 enhance connective tissue formation in animal models of dermal wound healing by secondary intent. Ann N Y Acad Sci (1990) 0.76
Transforming growth factors-beta 1 and beta 2 induce synthesis and accumulation of hyaluronate and chondroitin sulfate in vivo. Growth Factors (1990) 0.76
Removal of necrotic tissue with an ananain-based enzyme-debriding preparation. Wound Repair Regen (1996) 0.76
Immune response to inactivated syngeneic mammary adenocarcinoma cells. II. Parameters of immunogenicity in DBA/2 mice. J Natl Cancer Inst (1980) 0.76
Chondrocyte transplantation. Arthroscopy (1997) 0.75
Cross-reactivity of cell-mediated immunity between interstitial (type I) and basement membrane (type IV) collagens. J Exp Med (1982) 0.75
p53/TGF-beta/cancer: an intriguing connection. Cytokine Growth Factor Rev (1996) 0.75
The absence of antibodies to type II collagen in established adjuvant arthritis in rats. Agents Actions (1984) 0.75
Immune response to inactivated syngeneic mammary adenocarcinoma cells. I. Role and regulation of antibody synthesis in DBA/2 mice. J Natl Cancer Inst (1980) 0.75
Immune response to laminin, a noncollagenous glycoprotein of basement membrane, in a syngeneic murine system. Proc Soc Exp Biol Med (1982) 0.75
Immunologic unresponsiveness of mouse spleen sensitized to allogenic tumors. Cell Immunol (1977) 0.75
In vitro phosphorylation of type I collagen by cyclic AMP-dependent protein kinase. J Biol Chem (1986) 0.75
Unusual antiproliferative effects of transforming growth factors-beta 1 and beta 2 against primary cells from human tumors. Biotherapy (1989) 0.75
Osteogenesis in rats with an inductive bovine composite. J Orthop Res (1988) 0.75
Neutrophil response to LIF: lack of glucocorticoid effect despite enhanced chemokinesis. Inflammation (1983) 0.75
Efficacy of a novel hemostatic agent in animal models of impaired hemostasis. J Biomed Mater Res (2000) 0.75